“Irritable Bowel Syndrome Global Clinical Trials Review, H1, 2015″ provides data on the Irritable Bowel Syndrome clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Irritable Bowel Syndrome. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Irritable Bowel Syndrome. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData’s team of industry experts. Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease. Complete report available at http://www.rnrmarketresearch.com/irritable-bowel-syndrome-globalclinical-trials-review-h1-2015-market-report.html Scope
Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type Listings of discontinued trials (suspended, withdrawn and terminated)
Reasons To Buy
Understand the dynamics of a particular indication in a condensed manner Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more Obtain discontinued trial listing for trials across the globe Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies
Inquire for discount on this report @ http://www.rnrmarketresearch.com/contacts/discount?rname=268944 (Original Price Single User Licence $2500) Table of Contents 2 List of Tables 5 List of Figures 6 Introduction 7 Irritable Bowel Syndrome 7 Report Guidance 7 Clinical Trials by Region 8 Clinical Trials and Average Enrollment by Country 9 Top Five Countries Contributing to Clinical Trials in Asia-Pacific 11 Top Five Countries Contributing to Clinical Trials in Europe 12 Top Countries Contributing to Clinical Trials in North America 13
Top Five Countries Contributing to Clinical Trials in Middle East and Africa 14 Top Countries Contributing to Clinical Trials in Central and South America 15 Clinical Trials by G7 Countries: Proportion of Irritable Bowel Syndrome to Gastrointestinal Clinical Trials 16 Clinical Trials by Phase in G7 Countries 17 Clinical Trials in G7 Countries by Trial Status 18 Clinical Trials by E7 Countries: Proportion of Irritable Bowel Syndrome to Gastrointestinal Clinical Trials 19 Clinical Trials by Phase in E7 Countries 20 Buy a Copy of the report at http://www.rnrmarketresearch.com/contacts/purchase?rname=268944 For more information on Pharmaceuticals Market Contact sales@rnrmarketresearch.com / Call +1 888 391 5441 for further information on “Irritable Bowel Syndrome Global Clinical Trials Review, H1, 2015� report OR for any other market research and intelligence needs you may have for your business.